Tandem started a pivotal trial of a system that automatically stops insulin delivery when a patient’s blood glucose levels are predicted to fall.
The deal position Lakeland Health to roll out the system to give staff at its hospitals early warnings that a patient’s condition may deteriorate.
The partnerships give Alexion access to modeling and simulation software used by Celgene and a partner to support its push into genomics.
MannKind and One Drop are launching a study to gauge whether pairing the former's inhaled insulin with the latter's digital diabetes care platform…
The takeover will bolster Fresenius’ at-home dialysis unit, positioning it to profit if patients opt against receiving treatment in its care centers.
The takeover combines two George Church, Ph.D., cofounded startups to create a company equipped to sequence and make sense of genomes at scale.
23andMe, the Milken Institute and Lundbeck are recruiting 25,000 people for a genetic study on major depressive and bipolar disorders.
Theranos and Walgreens are settling a breach-of-contract lawsuit in which the drugstore giant demanded $140 million in damages.
Invitae has inked a pair of deals to acquire Good Start Genetics and CombiMatrix, gaining a foothold in the prenatal screening arena.
Cantel Medical has agreed to acquire Germany's BHT Group, which markets automated endoscope processing technology.